Inhibition of CAV1 attenuates diabetic cardiomyopathy through reducing ferroptosis via activating NRF2/GCLC signaling pathway
Theranostics · 31.03.2025 · 15 (11) · 4989-5006
DOI: 10.7150/thno.107367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, erschienen am 31.03.2025. Verfasst von Guangru Li und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology, School of Medicine, Nankai University; Department of Cardiology, Beichen Hospital, Nankai University, Tianjin, …. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, NF-E2-Related Factor 2, Ferroptosis, Caveolin 1. Die Arbeit wurde bisher 20-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pharmacology, School of Medicine, Nankai University; Department of Cardiology, Beichen Hospital, Nankai University, Tianjin, 300071, China.
- School of Medical Technology, Tianjin Medical University, Tianjin, 300203, China.
- The Third Central Hospital of Tianjin, 83 Jintang Road, Hedong District, Tianjin, 300170, China.
- Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases.
- Artificial Cell Engineering Technology Research Center, Tianjin, China.
- Tianjin Institute of Hepatobiliary Disease, Tianjin, China.
Zitieren
APA
Li, G., Liu, R., Peng, Z., Zhang, S., Sun, R., Wang, Z., Li, J., Gao, Y., Xu, Y., Cui, J., Liu, J., Yan, J., Cao, L., Ren, S., Chu, Y., Feng, L., Yang, L., Shen, Y., & Qi, Z. (2025). Inhibition of CAV1 attenuates diabetic cardiomyopathy through reducing ferroptosis via activating NRF2/GCLC signaling pathway. Theranostics, 15(11), 4989-5006. https://doi.org/10.7150/thno.107367
Vancouver
Li G, Liu R, Peng Z, Zhang S, Sun R, Wang Z, et al. Inhibition of CAV1 attenuates diabetic cardiomyopathy through reducing ferroptosis via activating NRF2/GCLC signaling pathway. Theranostics. 2025;15(11):4989-5006. doi:10.7150/thno.107367
BibTeX
@article{Li2025,
author = {Li, Guangru and Liu, Ruiqing and Peng, Zeyan and Zhang, Shengzheng and Sun, Runjia and Wang, Ziwei and Li, Jing and Gao, Yang and Xu, Yang and Cui, Jianlin and Liu, Jie and Yan, Jie and Cao, Lei and Ren, Shan and Chu, Yushun and Feng, Lifeng and Yang, Liang and Shen, Yanna and Qi, Zhi},
title = {Inhibition of CAV1 attenuates diabetic cardiomyopathy through reducing ferroptosis via activating NRF2/GCLC signaling pathway},
journal = {Theranostics},
year = {2025},
volume = {15},
number = {11},
pages = {4989--5006},
doi = {10.7150/thno.107367}
}
EUVIMED